South Miami, Florida Clinical Trials

A listing of South Miami, Florida clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 62 clinical trials
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma (AIRLYMPUS)

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, …

Research Institute of South Florida- Site Number : 8400023
 (4.3 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +50 other locations
A Study Evaluating The Safety Efficacy and Pharmacokinetics Of Ipatasertib In Combination With Atezolizumab And Docetaxel In Metastatic Castration-Resistant Prostate Cancer (mCRPC).

A study evaluating the safety, preliminary efficacy and pharmacokinetics of ipatasertib in combination with atezolizumab and docetaxel in participants with mCRPC previously treated with second-generation AR (Androgen Receptor)-targeted therapy. The study consists of two parts: [1] Part A: Safety run-in cohort of approximately 12 participants; [2] Part B: Expansion cohort …

adenocarcinoma
lymphadenopathy
metastatic hormone refractory prostate cancer
prostate adenocarcinoma
metastatic disease
Miami Cancer Institute of Baptist Health, Inc.
 (4.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +17 other locations
Assessment of the Efficacy Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

This study will be conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) compared to placebo for the treatment of agitation in participants with dementia of the Alzheimer's type.

Clinical Research Site
 (7.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

This is a multi-center, randomized, double-blind, placebo-controlled, parallel group 36 week multicenter Phase 2 study of two doses of CT1812 in adults with mild to moderate Alzheimer's Disease (AD).

Allied Biomedical Research Institute
 (2.6 away) Contact site
  • 0 views
  • 20 Sep, 2024
  • +10 other locations
Caterpillar Arterial Embolization Device Post-Market Study

The primary objective of this study is to evaluate the performance and safety of the Caterpillar Arterial Embolization Device when used for arterial embolization in the peripheral vasculature in a real world, on-label application.

Baptist Hospital of Miami
 (4.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +11 other locations
ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

This trial will evaluate the safety, efficacy, pharmacokinetics, fecal concentrations, and fecal microbiome effects of ACX-362E [ibezapolstat] in patients with C. difficile infection (CDI). The current record applies only to Segment 2A, primary completion date August 2020.

white blood cell count
stool test
aspart
diarrhea
Acurx Site #105
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Baby Item Learning and Development Study

The goal of this study is to experimentally test whether baby items can promote healthy infant development.

University of Miami
 (1.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Maximal Usage Pharmacokinetics and Safety of ARQ-151 in Adolescents and Adults With Chronic Plaque Psoriasis

This is a phase 1, open label, single arm study in which ARQ-151 cream 0.3% is applied QD for 2 weeks to adolescent subjects with chronic plaque psoriasis involving at least 10% body surface area (BSA) and adult subjects with chronic plaque psoriasis involving at least 20% BSA (excluding scalp). …

psoriasis
electrocardiogram
serum pregnancy test
psoriasis vulgaris
12 lead electrocardiogram
Arcutis Clinical Site 07
 (3.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +6 other locations
Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

To assess the effect of pimavanserin on the activities of daily living in subjects with Parkinson's Disease Psychosis

Premier Clinical Research Institute, Inc.
 (7.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +18 other locations
Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab

This is an open-label, multicenter study that includes a main study for all participants enrolled and an optional cerebrospinal fluid (CSF) sub-study. Self-identified African American (AA) and Hispanic or Latin American (HA) participants with a diagnosis of relapsing multiple sclerosis (RMS) will be enrolled. The treating neurologist must make an …

University of Miami Miller School of Medicine
 (7.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +30 other locations